美国药品NDC（国家药品编码）与药品说明书数据库（U.S. FDA National Drug Code DataBase）

NDC包装代码	产品NDC	产品类型	商品名	通用名	剂型	给药途径	上市日期	结束日期	市场类别	申请号	标签持有者	活性成分	规格	包装描述
52605-067-10	52605-067	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201	N/A	ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (52605-067-10)
52605-067-19	52605-067	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201	N/A	ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	7.5 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (52605-067-19)
52605-068-10	52605-068	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201	N/A	ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	15 mg/1	1000 TABLET, EXTENDED RELEASE in 1 BOTTLE (52605-068-10)
52605-068-13	52605-068	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201	N/A	ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	15 mg/1	30 TABLET, EXTENDED RELEASE in 1 BOTTLE (52605-068-13)
52605-068-19	52605-068	HUMAN PRESCRIPTION DRUG	Darifenacin	Darifenacin Hydrobromide	TABLET, EXTENDED RELEASE	ORAL	20201201	N/A	ANDA	ANDA211045	POLYGEN PHARMACEUTICALS INC.	DARIFENACIN HYDROBROMIDE	15 mg/1	90 TABLET, EXTENDED RELEASE in 1 BOTTLE (52605-068-19)